HHS extends liability shield to antivirals used for H1N1

The Department of Health and Human Services (HHS) recently provided a shield against damage claims related to the use of the antiviral drugs oseltamivir (Tamiflu) and zanamivir (Relenza) in the current H1N1 influenza pandemic. Continue reading

Swine Flu Scare: Stock Market Bonanza for “Politically Connected” BioTech Companies

The Swine Flu scare has boosted the stock market values of Big Pharma. Following initial reports from Mexico on the influenza outbreak, the demand for anti-flu drugs has skyrocketed.

Continue reading